2,3,4,5-Tetrahydro-7-(3,4-dichlorophenyl)-7H-[1,3]diazepino[2,1-a]isoindol-7-ol (54999-14-3)

Identification
Name:	2,3,4,5-Tetrahydro-7-(3,4-dichlorophenyl)-7H-[1,3]diazepino[2,1-a]isoindol-7-ol
Synonyms:	2,3,4,5-Tetrahydro-7-(3,4-dichlorophenyl)-7H-[1,3]diazepino[2,1-a]isoindol-7-ol
CAS:	54999-14-3
Molecular Formula:	C₁₈H₁₆Cl₂N₂O
Molecular Weight:	0
InChI:	InChI=1/C18H16Cl2N2O/c19-15-7-6-13(10-16(15)20)18(23)8-3-9-21-17-14-5-2-1-4-12(14)11-22(17)18/h1-8,10,17,21,23H,9,11H2
Molecular Structure:
Properties
Flash Point:	258.3°C
Boiling Point:	503.5°C at 760 mmHg
Density:	1.45g/cm³
Refractive index:	1.716
Flash Point:	258.3°C
Safety Data

Other Product

1H-Isoindol-1-one,octahydro-6,7a-dihydroxy-4-methyl-5-methylene-7-[4-methyl-7-(tetrahydro-5-oxo-2-furanyl)-1-heptenyl]-3-(phenylmethyl)-(9CI)
1/C7H8/c1-2-7-4-3-6(1)5-7/h1-4,6-7H,5H
3-[4-(4-Chlorobenzyl)-1-piperazinyl]-1-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)propan-2-ol benzoate
Spiro[7H-indeno[4,5-d]-1,3-dioxole-7,1'(2'H)-isoquinolin]-8-ol,3',4',6,8-tetrahydro-6',7'-dimethoxy-2'-methyl-, (1'S,8R)-
3-OXA-9-AZONIATRICYCLO(3.3.1.02,4))NONANE, 9-BUTYL-7-(3-HYDROXY-1-OXO-2-PHENYLPROPOXY)-9-METHYL-, (7(S)-(1-,2-,4-,5-,7-))-, SALT WITH 1,2,3,6-TETRAHYDRO-1,3-DIMETHYL-2,6-DIOXO-7H-PURINE-7-PROPANESULFONATE, HYDRATE (2:2:5)
3H-[1,3]Diazepino[2,1-a]isoindol-7-ol, 2,4,5,7-tetrahydro-7-phenyl-
Piperazine,1-(2-furanylcarbonyl)-4-[2-[1,2,3,6-tetrahydro-1-methyl-3-(2-methylpropyl)-2,6-dioxo-7H-purin-7-yl]ethyl]-
Piperazine,1-(phenylsulfonyl)-4-[2-[1,2,3,6-tetrahydro-1-methyl-3-(2-methylpropyl)-2,6-dioxo-7H-purin-7-yl]ethyl]-
3-Butyn-1-ol,4-[1,2,3,4-tetrahydro-4-(4-methoxyphenyl)-2-methyl-7-isoquinolinyl]-
3-Butyn-1-ol,4-[1,2,3,4-tetrahydro-4-(4-methoxyphenyl)-2-methyl-7-isoquinolinyl]-,methanesulfonate (ester)
1/C7H7N/c1-2-5-8-6-3-4-7-8/h3-7H,1H
N-[2-(4-chlorophenoxy)-2-methyl-1-phenylpropyl]-3-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)propanamide
7H-1-Benzopyran-7-one,2,3,4,8-tetrahydro-4-hydroxy-5-methoxy-8,8-bis(3-methyl-2-buten-1-yl)-2-phenyl-, (2S,4S)-
2H-Pyran-4-ol,tetrahydro-4-[3-[[[7-(1-hydroxyethyl)-5-phenyl-2-naphthalenyl]oxy]methyl]phenyl]-
2H-Pyran-4-ol,tetrahydro-4-[3-[[[7-(1-methoxyethyl)-5-phenyl-2-naphthalenyl]oxy]methyl]phenyl]-
N-(3-{4-Amino-7-[(2R,5S)-5-(hydroxymethyl)tetrahydro-2-furanyl]-7H-pyrrolo[2,3-d]pyrimidin-5-yl}-2-propyn-1-yl)-2,2,2-trifluoroacetamide
Furo[3,4-b]pyrazin-5(7H)-one,7-[4-(dihexadecylamino)phenyl]-7-(2-methyl-1-octyl-1H-indol-3-yl)-
1-Piperazinecarboxylicacid,4-[2-(benzoyloxy)-3-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)propyl]-,ethyl ester
1-Piperazinecarboxylic acid,4-[2-hydroxy-3-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)propyl]-, ethyl ester
Piperazine,1-[5-[3,4-bis[(2-methoxyethoxy)methoxy]phenyl]-1-oxo-2,4-pentadienyl]-4-[3-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)propyl]-,(E,E)-